Dr. Tomoko Iida

Dr. in Public Health (DrPH), MEng in Biomedical Engineering, MBA 

Sr. Director Scientific Engagement SAIC, CIS & MEA Region

Tomoko Iida is Senior Director of Scientific Engagement at Philip Morris International (PMI), focusing on the South Asia, Indochina, Commonwealth of Independent States, Middle East, and Africa regions. In this role, she aims to increase scientific awareness and understanding of tobacco harm reduction and smoke-free products.

Tomoko previously served as Director of Scientific Engagement for Asia, following 6 years of leading External and Scientific Affairs in Japan.

She holds a Doctor of Public Health degree (DrPH), a master’s degree in Biomedical Engineering and a bachelor’s degree in Chemical Engineering from the Massachusetts Institute of Technology (MIT), and a master’s degree in Business Administration (MBA) from the Imperial College London.

Tomoko has worked at MIT's Biotechnology Process Engineering Center and Sony Corporation's Life Science Laboratory in Japan.

Tomoko also advocates for Asian leadership and women in STEM (Science, technology, engineering, and mathematics).

Latest Publications

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.